BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 53 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $44,000 | -95.1% | 42,007 | -42.1% | 0.02% | -50.0% |
| Q1 2017 | $895,000 | +24.3% | 72,500 | -5.9% | 0.05% | +33.3% |
| Q1 2016 | $720,000 | -58.7% | 77,020 | -35.9% | 0.04% | -50.0% |
| Q3 2015 | $1,745,000 | -66.0% | 120,094 | -50.2% | 0.07% | -61.5% |
| Q2 2015 | $5,127,000 | -4.4% | 241,039 | +4.1% | 0.19% | -16.1% |
| Q1 2015 | $5,364,000 | -29.8% | 231,515 | -30.2% | 0.22% | -7.5% |
| Q4 2014 | $7,638,000 | – | 331,515 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |